Summary

Global Transradial Access Devices Market 2022-2026
Technavio has been monitoring the transradial access devices market and it is poised to grow by $ 927.10 mn during 2022-2026, progressing at a CAGR of 7.69% during the forecast period. Our report on the transradial access devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing number of percutaneous coronary intervention (PCI) procedures and technological advances. In addition, the increasing number of percutaneous coronary intervention (PCI) procedures is anticipated to boost the growth of the market as well.
The transradial access devices market analysis includes the application segment and geographic landscape.
Technavio's transradial access devices market is segmented as below:
By Application
• Drug administration
• Fluid and nutrition administration
• Diagnostics and testing
• Blood transfusion
By Geographical Landscape
• North America
• Europe
• Asia
• ROW
This study identifies the increasing R&D investments by pharmaceutical and biopharmaceutical companiesas one of the prime reasons driving the transradial access devices market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on transradial access devices market covers the following areas:
• Transradial access devices market sizing
• Transradial access devices market forecast
• Transradial access devices market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transradial access devices market vendors that include AngioDynamics Inc., Becton Dickinson and Co., Boston Scientific Corp., Edwards Lifesciences Corp., Medtronic Plc, Merit Medical Systems Inc., Nipro Medical Corp., OSCOR Inc., Teleflex Inc., and Terumo Medical Corp. Also, the transradial access devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/transradial-access-devices-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Drug administration - Market size and forecast 2021-2026
o Fluid and nutrition administration - Market size and forecast 2021-2026
o Diagnostics and testing - Market size and forecast 2021-2026
o Blood transfusion - Market size and forecast 2021-2026
o Market opportunity by Application
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AngioDynamics Inc.
o Becton Dickinson and Co.
o Boston Scientific Corp.
o Edwards Lifesciences Corp.
o Medtronic Plc
o Merit Medical Systems Inc.
o Nipro Medical Corp.
o OSCOR Inc.
o Teleflex Inc.
o Terumo Medical Corp
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Application - Market share 2021-2026 (%)
• 22: Comparison by Application
• 23: Drug administration - Market size and forecast 2021-2026 ($ million)
• 24: Drug administration - Year-over-year growth 2021-2026 (%)
• 25: Fluid and nutrition administration - Market size and forecast 2021-2026 ($ million)
• 26: Fluid and nutrition administration - Year-over-year growth 2021-2026 (%)
• 27: Diagnostics and testing - Market size and forecast 2021-2026 ($ million)
• 28: Diagnostics and testing - Year-over-year growth 2021-2026 (%)
• 29: Blood transfusion - Market size and forecast 2021-2026 ($ million)
• 30: Blood transfusion - Year-over-year growth 2021-2026 (%)
• 31: Market opportunity by Application
• 32: Customer landscape
• 33: Market share By Geographical Landscape 2021-2026 (%)
• 34: Geographic comparison
• 35: North America - Market size and forecast 2021-2026 ($ million)
• 36: North America - Year-over-year growth 2021-2026 (%)
• 37: Europe - Market size and forecast 2021-2026 ($ million)
• 38: Europe - Year-over-year growth 2021-2026 (%)
• 39: Asia - Market size and forecast 2021-2026 ($ million)
• 40: Asia - Year-over-year growth 2021-2026 (%)
• 41: ROW - Market size and forecast 2021-2026 ($ million)
• 42: ROW - Year-over-year growth 2021-2026 (%)
• 43: Key leading countries
• 44: Market opportunity By Geographical Landscape ($ million)
• 45: Impact of drivers and challenges
• 46: Vendor landscape
• 47: Landscape disruption
• 48: Industry risks
• 49: Vendors covered
• 50: Market positioning of vendors
• 51: AngioDynamics Inc. - Overview
• 52: AngioDynamics Inc. - Product and service
• 53: AngioDynamics Inc. - Key offerings
• 54: AngioDynamics Inc. - Key customers
• 55: AngioDynamics Inc. - Segment focus
• 56: Becton Dickinson and Co. - Overview
• 57: Becton Dickinson and Co. - Business segments
• 58: Becton Dickinson and Co. - Key offerings
• 59: Becton Dickinson and Co. - Key customers
• 60: Becton Dickinson and Co. - Segment focus
• 61: Boston Scientific Corp. - Overview
• 62: Boston Scientific Corp. - Business segments
• 63: Boston Scientific Corp. - Key offerings
• 64: Boston Scientific Corp. - Key customers
• 65: Boston Scientific Corp. - Segment focus
• 66: Edwards Lifesciences Corp. - Overview
• 67: Edwards Lifesciences Corp. - Business segments
• 68: Edwards Lifesciences Corp. - Key offerings
• 69: Edwards Lifesciences Corp. - Key customers
• 70: Edwards Lifesciences Corp. - Segment focus
• 71: Medtronic Plc - Overview
• 72: Medtronic Plc - Business segments
• 73: Medtronic Plc - Key offerings
• 74: Medtronic Plc - Key customers
• 75: Medtronic Plc - Segment focus
• 76: Merit Medical Systems Inc. - Overview
• 77: Merit Medical Systems Inc. - Business segments
• 78: Merit Medical Systems Inc. - Key offerings
• 79: Merit Medical Systems Inc. - Key customers
• 80: Merit Medical Systems Inc. - Segment focus
• 81: Nipro Medical Corp. - Overview
• 82: Nipro Medical Corp. - Product and service
• 83: Nipro Medical Corp. - Key offerings
• 84: Nipro Medical Corp. - Key customers
• 85: Nipro Medical Corp. - Segment focus
• 86: OSCOR Inc. - Overview
• 87: OSCOR Inc. - Product and service
• 88: OSCOR Inc. - Key offerings
• 89: OSCOR Inc. - Key customers
• 90: OSCOR Inc. - Segment focus
• 91: Teleflex Inc. - Overview
• 92: Teleflex Inc. - Business segments
• 93: Teleflex Inc. - Key offerings
• 94: Teleflex Inc. - Key customers
• 95: Teleflex Inc. - Segment focus
• 96: Terumo Medical Corp - Overview
• 97: Terumo Medical Corp - Business segments
• 98: Terumo Medical Corp - Key offerings
• 99: Terumo Medical Corp - Key customers
• 100: Terumo Medical Corp - Segment focus
• 101: Currency conversion rates for US$
• 102: Research Methodology
• 103: Validation techniques employed for market sizing
• 104: Information sources
• 105: List of abbreviations